Premium
Applying precision medicine to the active surveillance of prostate cancer
Author(s) -
Reichard Chad A.,
Stephenson Andrew J.,
Klein Eric A.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29496
Subject(s) - medicine , prostate cancer , cancer , intensive care medicine , precision medicine , gynecology , medical physics , pathology
The recent introduction of a variety of molecular tests will potentially reshape the care of patients with prostate cancer. These tests may make more accurate management decisions possible for those patients who have been “overdiagnosed” with biologically indolent disease, which represents an exceptionally small mortality risk. There is a wide range of possible applications of these tests to different clinical scenarios in patient populations managed with active surveillance. Cancer 2015;121:3435–43. © 2015 American Cancer Society .